FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3203410228> ?p ?o ?g. }

• W3203410228 endingPage "60" @default.
• W3203410228 startingPage "55" @default.
• W3203410228 abstract "The permissible gap method is an extensively used approach for defining episodes of continuous treatment use in pharmacoepidemiology. This method uses the amount of drug redeemed, when available, and researcher-defined temporal gaps to fill the interval between the calculated end of coverage of a redeemed prescription and the date of redemption of the next prescription in the same treatment episode. The final scope is defining periods of continuous use of medications. There are strong pharmacological and epidemiological arguments for adding the gap at the end of each treatment episode. However, the evidence is scarce on the impact that such a practice has on measures of association. This study aims to compare the impact of adding or not adding the researcher-defined gap time to the end of a treatment episode on the incidence of drug discontinuation and the incidence rate for a simulated outcome that occurred during an observational window. Additionally, the study aims at assessing the magnitude of misclassification of exposure time between the two methods.A simulated dataset of 100 patients available in the R package AdhereR that contains 1080 redeemed prescriptions was used. A gap time of 90 days was used for constructing treatment episodes in an observational window of 365 days following the first redeemed prescription. Two approaches were used for defining treatment episodes that were named gap+ and gap- and that respectively add and did not add the gap time at the end of a treatment episode. An outcome was simulated by using an exponential baseline hazard function with scale parameter λ = 0.5 and censoring at time t = 365 days. The incidence rate ratio for the simulated outcome between the two approaches was computed.The 100 patients were followed for a median time of 183 days (interquartile range, IQR 50-365 days) and a median time of 273 days (IQR 140-365 days), respectively using gap- and gap+. During the first 100 days of the follow-up period, none of the patients was found to discontinue the treatment with the method gap+ while 38 patients discontinued using the method gap-. The approach gap+ exerted a higher incidence rate for the simulated outcome among the exposed (0.98 events/person-years) when compared to the gap- (0.82 events/person-years) during defined periods of continuous treatment use. When comparing the two approaches and using the method gap- as the reference group, the incidence rate ratio for the simulated outcome was 1.20 (95% confidence interval: CI 0.72-2.02) among the exposed.This study showed that not adding the gap at the end of the treatment episodes leads to an overestimation of drug discontinuation, particularly at the beginning of the observational window, and an underestimation of the incidence rate of a hypothetical outcome during the period of exposure to the medication." @default.
• W3203410228 created "2021-10-11" @default.
• W3203410228 creator A5003383445 @default.
• W3203410228 creator A5025153351 @default.
• W3203410228 creator A5063723476 @default.
• W3203410228 date "2021-10-15" @default.
• W3203410228 modified "2023-10-15" @default.
• W3203410228 title "Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: A simulation study" @default.
• W3203410228 cites W1523572815 @default.
• W3203410228 cites W1975313736 @default.
• W3203410228 cites W1978209044 @default.
• W3203410228 cites W1999572242 @default.
• W3203410228 cites W2009421916 @default.
• W3203410228 cites W2028325814 @default.
• W3203410228 cites W2037280900 @default.
• W3203410228 cites W2051376020 @default.
• W3203410228 cites W2117317003 @default.
• W3203410228 cites W2136916987 @default.
• W3203410228 cites W2143404933 @default.
• W3203410228 cites W2159553172 @default.
• W3203410228 cites W2160291260 @default.
• W3203410228 cites W2470023581 @default.
• W3203410228 cites W2604581019 @default.
• W3203410228 cites W2768134151 @default.
• W3203410228 cites W2779763511 @default.
• W3203410228 cites W2793831746 @default.
• W3203410228 cites W2991156213 @default.
• W3203410228 doi "https://doi.org/10.1002/pds.5366" @default.
• W3203410228 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34611960" @default.
• W3203410228 hasPublicationYear "2021" @default.
• W3203410228 type Work @default.
• W3203410228 sameAs 3203410228 @default.
• W3203410228 citedByCount "4" @default.
• W3203410228 countsByYear W32034102282022 @default.
• W3203410228 countsByYear W32034102282023 @default.
• W3203410228 crossrefType "journal-article" @default.
• W3203410228 hasAuthorship W3203410228A5003383445 @default.
• W3203410228 hasAuthorship W3203410228A5025153351 @default.
• W3203410228 hasAuthorship W3203410228A5063723476 @default.
• W3203410228 hasBestOaLocation W32034102281 @default.
• W3203410228 hasConcept C107130276 @default.
• W3203410228 hasConcept C120665830 @default.
• W3203410228 hasConcept C121332964 @default.
• W3203410228 hasConcept C126322002 @default.
• W3203410228 hasConcept C187212893 @default.
• W3203410228 hasConcept C207103383 @default.
• W3203410228 hasConcept C23131810 @default.
• W3203410228 hasConcept C23276603 @default.
• W3203410228 hasConcept C2426938 @default.
• W3203410228 hasConcept C2778715236 @default.
• W3203410228 hasConcept C44249647 @default.
• W3203410228 hasConcept C61511704 @default.
• W3203410228 hasConcept C71924100 @default.
• W3203410228 hasConcept C98274493 @default.
• W3203410228 hasConceptScore W3203410228C107130276 @default.
• W3203410228 hasConceptScore W3203410228C120665830 @default.
• W3203410228 hasConceptScore W3203410228C121332964 @default.
• W3203410228 hasConceptScore W3203410228C126322002 @default.
• W3203410228 hasConceptScore W3203410228C187212893 @default.
• W3203410228 hasConceptScore W3203410228C207103383 @default.
• W3203410228 hasConceptScore W3203410228C23131810 @default.
• W3203410228 hasConceptScore W3203410228C23276603 @default.
• W3203410228 hasConceptScore W3203410228C2426938 @default.
• W3203410228 hasConceptScore W3203410228C2778715236 @default.
• W3203410228 hasConceptScore W3203410228C44249647 @default.
• W3203410228 hasConceptScore W3203410228C61511704 @default.
• W3203410228 hasConceptScore W3203410228C71924100 @default.
• W3203410228 hasConceptScore W3203410228C98274493 @default.
• W3203410228 hasFunder F4320325957 @default.
• W3203410228 hasIssue "1" @default.
• W3203410228 hasLocation W32034102281 @default.
• W3203410228 hasLocation W32034102282 @default.
• W3203410228 hasOpenAccess W3203410228 @default.
• W3203410228 hasPrimaryLocation W32034102281 @default.
• W3203410228 hasRelatedWork W2010040257 @default.
• W3203410228 hasRelatedWork W2039052235 @default.
• W3203410228 hasRelatedWork W2060361110 @default.
• W3203410228 hasRelatedWork W2360693916 @default.
• W3203410228 hasRelatedWork W2415484199 @default.
• W3203410228 hasRelatedWork W2419505618 @default.
• W3203410228 hasRelatedWork W3121096891 @default.
• W3203410228 hasRelatedWork W4243951464 @default.
• W3203410228 hasRelatedWork W4320086256 @default.
• W3203410228 hasRelatedWork W2464739384 @default.
• W3203410228 hasVolume "31" @default.
• W3203410228 isParatext "false" @default.
• W3203410228 isRetracted "false" @default.
• W3203410228 magId "3203410228" @default.
• W3203410228 workType "article" @default.